The Absorption, Metabolism and Excretion of [14C]D-0316 in Human
Clinical trial NCT04464551 · UNKNOWN
Trial details
- NCT number
- NCT04464551
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-05
- Primary completion
- 2021-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.